Market Tracker

09/19 5:34am ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

4.89
Data as of Sep 18
 -0.07 / -1.41%
Today’s Change
4.50
Today|||52-Week Range
7.82
-13.14%
Year-to-Date

Today’s Trading

Previous close4.96
Today’s open5.00
Day’s range-- - --
Volume3,517,168
Average volume (3 months)3,602,154
Market cap$607.8M
Dividend yield--
Data as of 09/18/2014

Growth & Valuation

Earnings growth (last year)+37.01%
Earnings growth (this year)+109.06%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales158.47
Price/Book12.44

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc+0.47+2.21%
ASPXAuspex Pharmaceutica...+0.09+0.42%
RGENRepligen Corp+0.08+0.41%
PRTAProthena Corporation...-0.73-3.09%
Data as of 09/18/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$3.4M
Annual profit (last year)-$77.7M
Net profit margin-2,265.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
CFO, Treasurer &
Chief Business Officer
Joseph P. Hagan
Corporate headquarters
La Jolla, California

Forecasts